Skip to main content
SpringerLink
Log in

Effect of catheter ablation on the left ventricular mass index and other echocardiograph parameters in atrial fibrillation patients: comparison with antiarrhythmic drug treatment

  • Original Investigation
  • Published:
Journal of Echocardiography Aims and scope Submit manuscript

Abstract

Background

Catheter ablation (CA) is reported to improve left ventricular (LV) function in patients with atrial fibrillation (AF). This study compared the effects of CA and antiarrhythmic drug treatment (AT) on LV remodeling and other echocardiography parameters in AF.

Methods

We performed a non-randomized prospective study involving 72 drug-resistant AF patients who were treated with either CA (n = 42) or who declined CA and continued on AT (n = 30). Baseline and follow-up (mean 20.7 ± 7.5 months) echocardiography was performed in all patients. The maintenance of sinus rhythm was determined based on clinical interview, electrocardiography, and 24-h Holter and event recording.

Results

There were no significant differences between the two groups in regard to demographic features, blood pressure, and medication. CA was superior to AT with respect to sinus rhythm maintenance, LV ejection fraction, left atrium (LA) diameter, and LA volume index. In addition, CA resulted in decreases in the LV mass [from 190.5 ± 36.1 to 179.3 ± 32.4 g (p = 0.02)] and the LV mass index [from 104.2 ± 20.5 to 98.2 ± 18.3 g/m2 (p = 0.03)]. No parameter improved in AT patients. These improved echocardiographic parameters were observed in both groups with maintained sinus rhythm.

Conclusion

Reverse LV remodeling after CA may include a reduction in the LV mass index, which appears to be associated with sinus rhythm maintenance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Noheria A, Kumar A, Wylie JV Jr, Josephson ME. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. Arch Intern Med. 2008;168:581–6.

    Article  PubMed  Google Scholar 

  2. Kim YH. Rhythm control versus rate control of atrial fibrillation: pharmacologic and non-pharmacologic therapy. Korean Circ J. 2003;33:553–8.

    Google Scholar 

  3. Jaïs P, Weerasooriya R, Shah DC, Hocini M, Macle L, Choi KJ, et al. Ablation therapy for atrial fibrillation (AF): past, present and future. Cardiovasc Res. 2002;54:337–46.

    Article  PubMed  Google Scholar 

  4. Roy D, Talajic M, Dubuc M, Thibault B, Guerra P, Macle L, et al. Atrial fibrillation and congestive heart failure. Curr Opin Cardiol. 2009;24:29–34.

    Article  PubMed  Google Scholar 

  5. Hsu LF, Jaïs P, Sanders P, Garrigue S, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med. 2004;351:2373–83.

    Article  PubMed  CAS  Google Scholar 

  6. Morrow JP, Reiffel JA. Drug therapy for atrial fibrillation: what will its role be in the era of increasing use of catheter ablation? Pacing Clin Electrophysiol. 2009;32:108–18.

    Article  PubMed  Google Scholar 

  7. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358:2667–77.

    Article  PubMed  CAS  Google Scholar 

  8. Novak PG. Effectiveness of catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation. Curr Opin Cardiol. 2009;24:9–17.

    Article  PubMed  Google Scholar 

  9. Jaïs P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118:2498–505.

    Article  PubMed  Google Scholar 

  10. Forleo GB, Mantica M, De Luca L, Leo R, Santini L, Panigada S, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol. 2009;20:22–8.

    Article  PubMed  Google Scholar 

  11. Reant P, Lafitte S, Jaïs P, Serri K, Weerasooriya R, Hocini M, et al. Reverse remodeling of the left cardiac chambers after catheter ablation after 1 year in a series of patients with isolated atrial fibrillation. Circulation. 2005;112:2896–903.

    PubMed  Google Scholar 

  12. Reant P, Lafitte S, Bougteb H, Sacher F, Mignot A, Douard H, et al. Effect of catheter ablation for isolated paroxysmal atrial fibrillation on longitudinal and circumferential left ventricular systolic function. Am J Cardiol. 2009;103:232–7.

    Article  PubMed  Google Scholar 

  13. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e257–354.

    Article  PubMed  Google Scholar 

  14. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613–8.

    PubMed  CAS  Google Scholar 

  15. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–8.

    Article  PubMed  CAS  Google Scholar 

  16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–63.

    Article  PubMed  Google Scholar 

  17. Al-Omari MA, Finstuen J, Appleton CP, Barnes ME, Tsang TS. Echocardiographic assessment of left ventricular diastolic function and filling pressure in atrial fibrillation. Am J Cardiol. 2008;101:1759–65.

    Article  PubMed  Google Scholar 

  18. Watanabe T, Iwai-Takano M, Oikawa M, Yamaki T, Yaoita H, Maruyama Y. Optimal noninvasive assessment of diastolic heart failure in patients with atrial fibrillation: comparison of tissue Doppler echocardiography, left atrium size, and brain natriuretic peptide. J Am Soc Echocardiogr. 2008;21:689–96.

    Article  PubMed  Google Scholar 

  19. Efremidis M, Sideris A, Xydonas S, Letsas KP, Alexanian IP, Manolatos D, et al. Ablation of atrial fibrillation in patients with heart failure: reversal of atrial and ventricular remodelling. Hellenic J Cardiol. 2008;49:19–25.

    PubMed  Google Scholar 

  20. Gentlesk PJ, Sauer WH, Gerstenfeld EP, Lin D, Dixit S, Zado E, et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18:9–14.

    Article  PubMed  Google Scholar 

  21. Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008;52:2148–55.

    Article  PubMed  Google Scholar 

  22. Gardin JM, Lauer MS. Left ventricular hypertrophy: the next treatable, silent killer? JAMA. 2004;292:2396–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

There is no conflict of interest in connection with any commercial associations.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Poongnap-dong 388-1, Songpa-gu, Seoul, 138-736, Korea

    Ki-Hun Kim, Jin Oh Na, Gi-Byoung Nam, Eun-Sun Jin, HyungOh Choi, Sung-Hwan Kim, Kee-Joon Choi & You-Ho Kim

Authors
  1. Ki-Hun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jin Oh Na
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gi-Byoung Nam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eun-Sun Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. HyungOh Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sung-Hwan Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kee-Joon Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. You-Ho Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gi-Byoung Nam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, KH., Na, J.O., Nam, GB. et al. Effect of catheter ablation on the left ventricular mass index and other echocardiograph parameters in atrial fibrillation patients: comparison with antiarrhythmic drug treatment. J Echocardiogr 9, 51–58 (2011). https://doi.org/10.1007/s12574-010-0069-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12574-010-0069-2

Keywords

Search

Navigation